Danone (OTCMKTS:DANOY) Hits New 12-Month Low – Here’s What Happened

Danone (OTCMKTS:DANOYGet Free Report) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $14.25 and last traded at $14.27, with a volume of 227123 shares changing hands. The stock had previously closed at $14.38.

Analyst Ratings Changes

A number of equities analysts have issued reports on DANOY shares. Kepler Capital Markets raised Danone to a “strong-buy” rating in a research note on Wednesday, February 11th. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Danone in a research note on Thursday, May 7th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Danone in a research note on Monday, February 23rd. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

Check Out Our Latest Analysis on DANOY

Danone Price Performance

The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.75 and a current ratio of 0.90. The company’s 50-day moving average price is $15.42 and its two-hundred day moving average price is $16.64.

Danone Company Profile

(Get Free Report)

Danone is a French multinational food-products company headquartered in Paris, with roots dating to 1919 when it was founded by Isaac Carasso. The company positions itself around nutrition and health-oriented food and beverage products, and it combines global brand management, manufacturing and distribution to serve a broad consumer base. Danone’s long history has been characterized by expansion beyond its original yogurt business into bottled water, infant and medical nutrition, and plant-based alternatives.

Danone’s principal activities include the development, production and marketing of dairy and plant-based products, bottled waters, and specialized nutrition for infants and medical patients.

See Also

Receive News & Ratings for Danone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danone and related companies with MarketBeat.com's FREE daily email newsletter.